Ordering Recommendation

Useful for monitoring treatment response and for assessing monoclonal antibody interference for patients with IgG kappa multiple myeloma being treated with daratumamab.

Mnemonic

MM DARA

Methodology

Qualitative Immunofixation Electrophoresis

Performed

Varies

Reported

4-9 days

New York DOH Approval Status

This test is New York DOH approved.

Specimen Required

Patient Preparation

Fasting specimen preferred.

Collect

Plain Red.

Specimen Preparation

Transfer 2 mL serum to an ARUP Standard Transport Tube. (Min: 1 mL)
Test is not performed at ARUP; separate specimens must be submitted when multiple tests are ordered.

Storage/Transport Temperature

Refrigerated. Also acceptable: Room temperature or frozen.

Unacceptable Conditions
Remarks
Stability

Ambient: 5 days; Refrigerated: 6 days; Frozen: 6 months

Reference Interval

By report

Interpretive Data



Compliance Category

Note

Hotline History

N/A

CPT Codes

86334

Components

Component Test Code* Component Chart Name LOINC
3003972 Multiple Myeloma, Daratumumab, Interp 96420-5
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.

Aliases

  • DARA
  • Darzalex
Multiple Myeloma, Daratumamab, Immunofixation

Quest Diagnostics San Juan Capistrano Inc.